Skip to main navigation Skip to search Skip to main content

A Phase 2 Study of Ianalumab in Patients with Primary Immune Thrombocytopenia Previously Treated with at Least Two Lines of Therapy: Interim Results from VAYHIT3

  • David J Kuter
  • , Tomas Jose Gonzalez Lopez
  • , Karolin Trautmann-Grill
  • , Mathias J. Rummel
  • , Philip Young-Ill Choi
  • , Alessandra Borchiellini
  • , Muhlis Cem Ar
  • , Huyen Tran
  • , Tienan Zhu
  • , Jae-Ho Yoon
  • , Nichola Cooper
  • , Thomas Stauch
  • , Pinar Tarkun
  • , Fabienne Le Gac
  • , Alex Allepuz
  • , Patrick Urban
  • , Renxin Lin
  • , Charlotte A. Bradbury

Research output: Contribution to journal › Article (Academic Journal) › peer-review

Original languageEnglish
Pages (from-to)710
JournalBlood
Volume144
Issue numberSupplement 1
DOIs
Publication statusPublished - 5 Nov 2024

Cite this